Quadrant Capital Group LLC Spectrum Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$0.63 - $1.59 $223 - $562	-354 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$1.27 - $2.42 $67 - $128	53 Added 17.61%	354 $0
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.82 $4,289 - $7,620	-1,995 Reduced 86.89%	301 $1,000
Q4 2020 Feb 16, 2021	SELL	$3.38 - $5.14 $128 - $195	-38 Reduced 1.63%	2,296 $8,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $113 - $186	38 Added 1.66%	2,334 $10,000
Q2 2020 Aug 13, 2020	BUY	$2.11 - $3.38 $4,437 - $7,108	2,103 Added 1089.64%	2,296 $8,000
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $353 - $665	193 New	193 $0
Q2 2018 Aug 09, 2018	SELL	$14.31 - $21.75 $601 - $913	-42 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$16.09 - $23.07 $675 - $968	42 New	42 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.